Schiavi SC, Kumar R (2004) The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 65:1–14
CAS PubMed Article Google Scholar
Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R (1994) Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 330:1645–1649
CAS PubMed Article Google Scholar
Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98:6500–6505
CAS PubMed PubMed Central Article Google Scholar
Ryan EA, Reiss E (1984) Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med 77:501–512
CAS PubMed Article Google Scholar
Weidner N, Santa Cruz D (1987) Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59:1442–1454
CAS PubMed Article Google Scholar
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT (2021) Tumor-induced osteomalacia. Calcif Tissue Int 108:128–142
CAS PubMed Article Google Scholar
Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, Zhang HB, Li F, Jing HL, Zhong DR, Jin J, Gao P, Zhou L, Qi F, Yu W, Bilezikian JP, Meng XW (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res 27:1967–1975
Paquet M, Gauthé M, Zhang Yin J, Nataf V, Bélissant O, Orcel P, Roux C, Talbot JN, Montravers F (2018) Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours. Eur J Nucl Med Mol Imaging 45:1710–1720
Meyer M, Nicod Lalonde M, Testart N, Jreige M, Kamani C, Boughdad S, Muoio B, Becce F, Schaefer N, Candrian C, Giovanella L, Prior JO, Treglia G, Riegger M (2019) Detection rate of culprit tumors causing osteomalacia using somatostatin receptor PET/CT: systematic review and meta-analysis. Diagnostics (Basel) 10
El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) 68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101:3575–3581
CAS PubMed PubMed Central Article Google Scholar
Crouzet J, Mimoune H, Beraneck L, Juan LH (1995) Hypophosphatemic osteomalacia with plantar neurilemoma. A review of the literature (100 cases). Rev Rhum Engl Ed 62:463–466
Weidner N, Bar RS, Weiss D, Strottmann MP (1985) Neoplastic pathology of oncogenic osteomalacia/rickets. Cancer 55:1691–1705
CAS PubMed Article Google Scholar
Drezner MK (2001) Tumor-induced osteomalacia. Rev Endocr Metab Disord 2:175–186
CAS PubMed Article Google Scholar
Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53–R77
CAS PubMed PubMed Central Article Google Scholar
Rendina D, Abate V, Cacace G, Elia L, De Filippo G, Del Vecchio S, Galletti F, Cuocolo A, Strazzullo P (2022) Tumor induced osteomalacia: a systematic review and individual patient's data analysis. J Clin Endocrinol Metab
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18:e1003583
PubMed PubMed Central Article Google Scholar
Moorjani R, Shaw DG (1976) Feuerstein and Mims syndrome with resistant rickets. Pediatr Radiol 5:120–122
CAS PubMed Article Google Scholar
Carey DE, Drezner MK, Hamdan JA (1986) Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia. J Pediatr 109:994–1000
CAS PubMed Article Google Scholar
Saville PD, Nassim JR, Stevenson FH, Mulligan L, Carey M (1955) Osteomalacia in Von Recklinghausen’s neurofibromatosis; metabolic study of a case. Br Med J 1:1311–1313
CAS PubMed PubMed Central Article Google Scholar
Konishi K, Nakamura M, Yamakawa H, Suzuki H, Saruta T, Hanaoka H, Davatchi F (1991) Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 301:322–328
CAS PubMed Article Google Scholar
Dent CE, Gertner JM (1976) Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med 45:411–420
Dutta S, Bagga A (1999) McCune Albright syndrome and hypophosphatemic rickets. Indian J Pediatr 66:628–631
CAS PubMed Article Google Scholar
Rao DS, Parfitt AM, Villanueva AR, Dorman PJ, Kleerekoper M (1987) Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. Am J Med 82:333–338
CAS PubMed Article Google Scholar
Narvaez J, Domingo-Domenech E, Narvaez JA, Nolla JM, Valverde J (2005) Acquired hypophosphatemic osteomalacia associated with multiple myeloma. Jt Bone Spine 72:424–426
Chua SC, O’Connor SR, Wong WL, Ganatra RH (2008) Case report: solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET/CT. A case report with a review of the radiological literature. Br J Radiol 81:e110-114
CAS PubMed Article Google Scholar
Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310
CAS PubMed Article Google Scholar
Wesseling-Perry K (2011) FGF23: is it ready for prime time? Clin Chem 57:1476–1477
CAS PubMed Article Google Scholar
Fontanarosa P, Christiansen S (2007) Units of measure. In: Press OU (ed) AMA manual of style: a guide for authors and editors. Oxford University Press, New York, pp 787–820
Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, de Beur SMJ, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O’Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White FKE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity—an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28:1–30
Nuovo MA, Dorfman HD, Sun CC, Chalew SA (1989) Tumor-induced osteomalacia and rickets. Am J Surg Pathol 13:588–599
CAS PubMed Article Google Scholar
Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294:1260–1267
Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044
Shah R, Lila AR, Ramteke-Jadhav S, Patil V, Mahajan A, Sonawane S, Thadani P, Dcruz A, Pai P, Bal M, Kane S, Shah N, Bandgar T (2019) Tumor induced osteomalacia in head and neck region: single center experience and systematic review. Endocr Connect 8:1330–1353
CAS PubMed PubMed Central Article Google Scholar
Nawrot-Wawrzyniak K, Varga F, Nader A, Roschger P, Sieghart S, Zwettler E, Roetzer KM, Lang S, Weinkamer R, Klaushofer K, Fratzl-Zelman N (2009) Effects of tumor-induced osteomalacia on the bone mineralization process. Calcif Tissue Int 84:313–323
CAS PubMed Article Google Scholar
Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL (1997) Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res 12:1502–1511
CAS PubMed Article Google Scholar
Jerkovich F, Nuñez S, Mocarbel Y, Pignatta A, Elías N, Cassinelli H, Díaz AG, Vigovich C, Balonga MC, Cohen AC, Mumbach G, Gonzalez S, Zanchetta JR, Zanchetta MB (2020) Burden of disease in patients with tumor-induced osteomalacia. JBMR plus 5:e10436–e10436
PubMed PubMed Central Google Scholar
Colangelo L, Pepe J, Nieddu L, Sonato C, Scillitani A, Diacinti D, Angelozzi M, Cipriani C, Minisola S (2020) Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia. Osteoporosis Int
Zanchetta MB, Jerkovich F, Nuñez S, Mocarbel Y, Pignatta A, Elías N, Díaz AG, Roganovich JM, Vigovich C, Balonga MC, Cohen AC, Mumbach G, Gonzalez S, Plantalech L, Fradinger E, Zanchetta JR (2021) Impaired bone microarchitecture and strength in patients with tumor-induced osteomalacia. J Bone Miner Res 36:1502–1509
CAS PubMed Article Google Scholar
Feng J, Jiang Y, Wang O, Li M, Xing X, Huo L, Li F, Yu W, Zhong DR, Jin J, Liu Y, Qi F, Lv W, Zhou L, Meng XW, Xia WB (2017) The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J 64:675–683
Dahir K, Zanchetta MB, Stanciu I, Robinson C, Lee JY, Dhaliwal R, Charles J, Civitelli R, Roberts MS, Krolczyk S, Weber T (2021) Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience. J Endocr Soc 5:bvab099
Pal R, Bhadada SK, Singhare A, Bhansali A, Kamalanathan S, Chadha M, Chauhan P, Sood A, Dhiman V, Sharma DC, Saikia UN, Chatterjee D, Agashe V (2019) Tumor-induced osteomalacia: experience from three tertiary care centers in India. Endocr Connect 8:266–276
留言 (0)